Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02061761 |
| Title | Safety Study of Anti-LAG-3 in Relapsed or Refractory Hematologic Malignancies |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Bristol-Myers Squibb |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Local Institution - 0007 | Baltimore | Maryland | 21205 | United States | Details | |
| Local Institution - 0004 | Boston | Massachusetts | 02215 | United States | Details | |
| Barbara Ann Karmanos Cancer Institute | Detroit | Michigan | 48201 | United States | Details | |
| Local Institution - 0010 | Saint Louis | Missouri | 63110 | United States | Details | |
| Weill Cornell Medical College | New York | New York | 10021 | United States | Details | |
| Local Institution - 0002 | Portland | Oregon | 97239 | United States | Details | |
| Local Institution - 0006 | Houston | Texas | 77030 | United States | Details | |
| Local Institution - 0001 | Seattle | Washington | 98109 | United States | Details | |
| Local Institution - 0011 | Vancouver | British Columbia | V5Z 4E6 | Canada | Details | |
| Local Institution - 0012 | Toronto | Ontario | M5G 2M9 | Canada | Details |